Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FACTOR-FACTOR VIIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 413 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Eikenboom, JCJ
      Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    2. Kaiser, B; Hoppensteadt, DA; Fareed, J
      Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    3. Cooper, HA; Jones, CP; Campion, E; Roberts, HR; Hedner, U
      Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures

      HAEMOPHILIA
    4. Godreuil, S; Navarro, R; Quittet, P; Landreau, L; Schved, JF; Biron-Andreani, C
      Acquired haemophilia in the elderly is a severe disease: report of five new cases

      HAEMOPHILIA
    5. Ekert, H; Brewin, T; Boey, W; Davey, P; Tilden, D
      Cost-utility analysis of recombinant factor VIIa (NovoSeven((R))) in six children with long-standing inhibitors to factor VIII or IX

      HAEMOPHILIA
    6. Faradji, A; Bonnomet, F; Lecocq, J; Grunebaum, L; Desprez, D; Kern, O; Barbier, L; Sibilia, J
      Knee joint arthroplasty in a patient with haemophilia A and high inhibitortitre using recombinant factor VIIa (NovoSeven((R))): a new case report and review of the literature

      HAEMOPHILIA
    7. Penner, JA
      Haemophilic patients with inhibitors to factor VIII or IX: variables affecting treatment response

      HAEMOPHILIA
    8. Aledort, LM
      Making a therapeutic choice: human versus recombinant fractions - can we do it?

      HAEMOPHILIA
    9. Hoots, WK
      The future of plasma-derived clotting factor concentrates

      HAEMOPHILIA
    10. Blajchman, MA
      Novel platelet products, substitutes and alternatives

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    11. Castro, RR; Relinque, NB; Alvarez, AC; Montes, JMG; Gutierrez, JMH
      Use of recombinant factor VII in Hepatology

      REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    12. Mackman, N
      Gene targeting in hemostasis. Tissue factor

      FRONTIERS IN BIOSCIENCE
    13. Rao, CN; Lakka, SS; Kin, Y; Konduri, SD; Fuller, GN; Mohanam, S; Rao, JS
      Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas

      CLINICAL CANCER RESEARCH
    14. Schatteman, K; Goossens, F; Leurs, J; Verkerk, R; Scharpe, S; Michiels, JJ; Hendriks, D
      Carboxypeptidase U at the interface between coagulation and fibrinolysis

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    15. Luther, T; Mackman, N
      Tissue factor in the heart - Multiple roles in hemostasis, thrombosis, andinflammation

      TRENDS IN CARDIOVASCULAR MEDICINE
    16. Peppelenbosch, MP; Versteeg, HH
      Cell biology of tissue factor, an unusual member of the cytokine receptor family

      TRENDS IN CARDIOVASCULAR MEDICINE
    17. Rao, LVM; Pendurthi, UR
      Factor VIIa-induced gene expression: Potential implications in pathophysiology

      TRENDS IN CARDIOVASCULAR MEDICINE
    18. Eigenbrot, C; Kirchhofer, D; Dennis, MS; Santell, L; Lazarus, RA; Stamos, J; Ultsch, MH
      The factor VII zymogen structure reveals reregistration of beta strands during activation

      STRUCTURE
    19. Young, WB; Kolesnikov, A; Rai, R; Sprengeler, PA; Leahy, EM; Shrader, WD; Sangalang, J; Burgess-Henry, J; Spencer, J; Elrod, K; Cregar, L
      Optimization of a screening lead for factor VIIa/TF

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    20. Cardigan, RA; Crook, M; Mackie, IJ; Machin, SJ
      Plasma levels of factor XIIa and factor VIIa are increased but not relatedin primary hyperlipidaemia

      BLOOD COAGULATION & FIBRINOLYSIS
    21. Meijer, K; Peters, FTM; van der Meer, J
      Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand's disease, controlled with recombinant factor VIIa

      BLOOD COAGULATION & FIBRINOLYSIS
    22. Konduri, SD; Rao, CN; Chandrasekar, N; Tasiou, A; Mohanam, S; Kin, Y; Lakka, SS; Dinh, D; Olivero, WC; Gujrati, M; Foster, DC; Kisiel, W; Rao, JS
      A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion

      ONCOGENE
    23. Rickles, FR; Shoji, M; Abe, K
      The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: Tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    24. Villoutreix, BO; Covell, DG; Blom, AM; Wallqvist, A; Friedrich, U; Dahlback, B
      Screening the molecular surface of human anticoagulant protein C: A searchfor interaction sites

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    25. Hall, RL; Leahy, MF
      Acquired Factor VIII autoantibody: four cases demonstrating the heterogenous nature of this condition and problems involved in diagnosis and treatment

      EUROPEAN JOURNAL OF HAEMATOLOGY
    26. Robbins, D; Kulkarni, R; Gera, R; Scott-Emuakpor, AB; Bosma, K; Penner, JA
      Successful treatment of high titer inhibitors in mild hemophilia a with avoidance of factor VIII and immunosuppressive therapy

      AMERICAN JOURNAL OF HEMATOLOGY
    27. Kulkarni, R; Aledort, LM; Berntorp, E; Brackman, HH; Brown, D; Cohen, AR; Ewing, NP; Gringeri, A; Gruppo, R; Hoots, K; Leissenger, C; Peerlinck, K; Poon, MC; Wong, WY
      Therapeutic choices for patients with hemophilia and high-titer inhibitors

      AMERICAN JOURNAL OF HEMATOLOGY
    28. Friederich, PW; Wever, PC; Briet, E; Doorenbos, CJ; Levi, M
      Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease

      AMERICAN JOURNAL OF HEMATOLOGY
    29. Bromberg, ME; Bailly, MA; Konigsberg, WH
      Role of protease-activated receptor 1 in tumor metastasis promoted by tissue factor

      THROMBOSIS AND HAEMOSTASIS
    30. Smith, MP; Ludlam, CA; Collins, PW; Hay, CRM; Wilde, JT; Grigeri, A; Melsen, T; Savidge, GF
      Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII - Plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding

      THROMBOSIS AND HAEMOSTASIS
    31. Bajaj, MS; Birktoft, JJ; Steer, SA; Bajaj, SP
      Structure and biology of tissue factor pathway inhibitor

      THROMBOSIS AND HAEMOSTASIS
    32. Konigsberg, W; Kirchhofer, D; Riederer, MA; Nemerson, Y
      The TF : VIIa complex: Clinical significance, structure-function relationships and its role in signaling and metastasis

      THROMBOSIS AND HAEMOSTASIS
    33. Esmon, CT
      Role of coagulation inhibitors in inflammation

      THROMBOSIS AND HAEMOSTASIS
    34. Morrissey, JH
      Tissue factor: An enzyme cofactor and a true receptor

      THROMBOSIS AND HAEMOSTASIS
    35. Perera, L; Darden, TA; Pedersen, LG
      Modeling human zymogen factor IX

      THROMBOSIS AND HAEMOSTASIS
    36. Presta, L; Sims, P; Meng, YG; Moran, P; Bullens, S; Bunting, S; Schoenfeld, J; Lowe, D; Lai, J; Rancatore, P; Iverson, M; Lim, A; Chisholm, V; Kelley, RF; Riederer, M; Kirchhofer, D
      Generation of a humanized,high affinity anti-tissue factor antibody for use as a novel antithrombotic therapeutic

      THROMBOSIS AND HAEMOSTASIS
    37. Iakhiaev, A; Ruf, W; Rao, LVM
      The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor

      THROMBOSIS AND HAEMOSTASIS
    38. Himber, J; Refino, CJ; Burcklen, L; Roux, S; Kirchhofer, D
      Inhibition of arterial thrombosis by a soluble tissue factor mutant and active site-blocked factors IXa and Xa in the guinea pig

      THROMBOSIS AND HAEMOSTASIS
    39. Blatt, J; Gold, SH; Wiley, JM; Monahan, PE; Cooper, HC; Harvey, D
      Off-label use of recombinant factor VIIa in patients following bone marrowtransplantation

      BONE MARROW TRANSPLANTATION
    40. Levesque, H; Borg, JY; Bossi, P; Goudemand, J; Guillet, B; Cabane, J
      Acquired haemophilia: diagnosis and therapeutic management.

      REVUE DE MEDECINE INTERNE
    41. Warren, BL; Eid, A; Singer, P; Pillay, SS; Carl, P; Novak, I; Chalupa, P; Atherstone, A; Penzes, I; Kubler, A; Knaub, S; Keinecke, HO; Heinrichs, H; Schindel, F; Juers, M; Bone, RC; Opal, SM
      High-dose a randomized antithrombin III in severe sepsis - A randomized controlled trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    42. Erhardtsen, E; Nilsson, P; Johannessen, M; Thomsen, MS
      Pharmacokinetics and safety of FFR-rFVIIa after single doses in healthy subjects

      JOURNAL OF CLINICAL PHARMACOLOGY
    43. Taylor, FB; Haddad, PA; Hack, E; Chang, AC; Peer, GT; Morrissey, JH; Li, AG; Allen, RC; Wada, H; Kinasewitz, GT
      Two-stage response to endotoxin infusion into normal human subjects: Correlation of blood phagocyte luminescence with clinical and laboratory markersof the inflammatory, hemostatic response

      CRITICAL CARE MEDICINE
    44. Tomokiyo, K; Teshima, K; Nakatomi, Y; Watanabe, T; Mizuguchi, J; Nozaki, C; Nakagaki, T; Miyamoto, S; Funatsu, A; Iwanaga, S
      Induction of acquired factor IX inhibitors in cynomolgus monkey (Macaca fascicularis): A new primate model of hemophilia B

      THROMBOSIS RESEARCH
    45. Ahmad, S; Jeske, WP; Ma, Q; Walenga, JM; Fareed, J
      Inhibition of tissue factor-activated platelets by low-molecular-weight heparins and glycoprotein IIb/IIIa receptor antagonist

      THROMBOSIS RESEARCH
    46. Elg, M; Carlsson, S; Gustafsson, D
      Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits

      THROMBOSIS RESEARCH
    47. Shapiro, A
      Inhibitor treatment: State of the art

      SEMINARS IN HEMATOLOGY
    48. Welty-Wolf, KE; Carraway, MS; Idell, S; Ortel, TL; Ezban, M; Piantadosi, CA
      Tissue factor in experimental acute lung injury

      SEMINARS IN HEMATOLOGY
    49. Petersen, LC
      Active site-inhibited seven: Mechanism of action including signal transduction

      SEMINARS IN HEMATOLOGY
    50. Riewald, M; Ruf, W
      Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    51. Mizuno, H; Fujimoto, Z; Atoda, H; Morita, T
      Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    52. Kurniawan, ND; Aliabadizadeh, K; Brereton, IM; Kroon, PA; Smith, R
      NMR structure and backbone dynamics of a concatemer of epidermal growth factor homology modules of the human low-density lipoprotein receptor

      JOURNAL OF MOLECULAR BIOLOGY
    53. Jin, JP; Perera, L; Stafford, D; Pedersen, L
      Four loops of the catalytic domain of factor VIIa mediate the effect of the first EGF-like domain substitution on factor VIIa catalytic activity

      JOURNAL OF MOLECULAR BIOLOGY
    54. Persson, E; Bak, H; Olsen, OH
      Substitution of valine for leucine 305 in factor VIIa increases the intrinsic enzymatic activity

      JOURNAL OF BIOLOGICAL CHEMISTRY
    55. Andersson, D; Carlsson, U; Freskgard, PO
      Contribution of tryptophan residues to the CD spectrum of the extracellular domain of human tissue factor - Application in folding studies and prediction of secondary structure

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    56. Penn, MS; Topol, EJ
      Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling

      CIRCULATION RESEARCH
    57. Singh, R; Pan, SC; Mueske, CS; Witt, T; Kleppe, LS; Peterson, TE; Slobodova, A; Chang, JY; Caplice, NM; Simari, RD
      Role for tissue factor pathway in murine model of vascular remodeling

      CIRCULATION RESEARCH
    58. Atsuchi, N; Nishida, T; Marutsuka, K; Asada, Y; Kamikubo, Y; Takeshita, A; Ueno, H
      Combination of a brief irrigation with tissue factor pathway inhibitor (TFPI) and adenovirus-mediated local TFPI gene transfer additively reduces neointima formation in balloon-injured rabbit carotid arteries

      CIRCULATION
    59. Chu, AJ; Wang, ZG; Nwobi, OI; Beydoun, S
      Blockade by ruthenium red of tissue factor-initiated coagulation

      BRITISH JOURNAL OF PHARMACOLOGY
    60. Lee, DH; Blajchman, MA
      Novel treatment modalities: New platelet preparations and subsititutes

      BRITISH JOURNAL OF HAEMATOLOGY
    61. Kjalke, M; Ezban, M; Monroe, DM; Hoffman, M; Roberts, HR; Hedner, U
      High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system

      BRITISH JOURNAL OF HAEMATOLOGY
    62. Patel, RK; Savidge, GF; Rangarajan, S
      Use of recombinant factor VIIA for post-operative haemorrhage in a patientwith Glanzmann's thrombasthenia and human leucocyte antigen antibodies

      BRITISH JOURNAL OF HAEMATOLOGY
    63. Kulkarni, R; Lusher, J
      Perinatal management of newborns with haemophilia

      BRITISH JOURNAL OF HAEMATOLOGY
    64. Ghrib, F; Leger, P; Ezban, M; Kristensen, AT; Cambus, JP; Boneu, B
      Anti-thrombotic and haemorrhagic effects of active site-inhibited factor VIIa in rats

      BRITISH JOURNAL OF HAEMATOLOGY
    65. Smyth, SS; Reis, ED; Vaananen, H; Zhang, W; Coller, BS
      Variable protection of beta 3-integrin-deficient mice from thrombosis initiated by different mechanisms

      BLOOD
    66. Peyvandi, F; Carew, JA; Perry, DJ; Hunault, M; Khanduri, U; Perkins, SJ; Mannucci, PM; Bauer, KA
      Abnormal secretion and function of recombinant human factor VII as the result of modification to a calcium binding site caused by a 15-base pair insertion in the F7 gene

      BLOOD
    67. Riewald, M; Kravchenko, VV; Petrovan, RJ; O'Brien, PJ; Brass, LF; Ulevitch, RJ; Ruf, W
      Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1

      BLOOD
    68. Jin, JP; Chang, JL; Stafford, DW; Straight, DL
      Residues Y179 and H101 of a hydrophobic patch of factor VII are involved in activation by factor Xa

      BIOCHEMISTRY
    69. Persson, E; Nielsen, LS; Olsen, OH
      Substitution of aspartic acid for methionine-306 in factor VIIa abolishes the allosteric linkage between the active site and the binding interface with tissue factor

      BIOCHEMISTRY
    70. Melis, E; Moons, L; De Mol, M; Herbert, JM; Mackman, N; Collen, D; Carmeliet, P; Dewerchin, M
      Targeted deletion of the cytosolic domain of tissue factor in mice does not affect development

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    71. Herbert, JM; de Prost, D; Ollivier, V; Melis, E; Carmeliet, P
      Tissue factor is not involved in the mitogenic activity of factor VIIa

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    72. Zillmann, A; Luther, T; Muller, I; Kotzsch, M; Spannagl, M; Kauke, T; Oelschlagel, U; Zahler, S; Engelmann, B
      Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    73. Warkentin, TE
      Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis

      ANNALS OF INTERNAL MEDICINE
    74. Bayani, N; Lelong, F
      Acquired factor VIIIc inhibitors. Two cases and a review of the literature

      ANNALES DE MEDECINE INTERNE
    75. Gale, AJ; Gordon, SG
      Update on tumor cell procoagulant factors

      ACTA HAEMATOLOGICA
    76. Martinowitz, U; Kenet, G; Segal, E; Luboshitz, J; Lubetsky, A; Ingerslev, J; Lynn, M
      Recombinant activated factor VII for adjunctive hemorrhage control in trauma

      JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
    77. Martinowitz, U; Holcomb, JB; Pusateri, AE; Stein, M; Onaca, N; Freidman, M; Macaitis, JM; Castel, D; Hedner, U; Hess, JR
      Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries

      JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
    78. Lusher, JM
      Inhibitors in young boys with haemophilia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    79. Tagariello, G; De Biasi, E; Gajo, GB; Risato, R; Radossi, P; Davoli, PG; Traldi, A
      Recombinant FVIIa (NovoSeven) continuous infusion and total hip replacement in patients with haemophilia and high titre of inhibitors to FVIII: experience of two cases

      HAEMOPHILIA
    80. Unuvar, A; Warrier, I; Lusher, JM
      Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors

      HAEMOPHILIA
    81. Cohen, I; Heim, M; Martinowitz, U; Chechick, A
      Orthopaedic outcome of total knee replacement in Haemophilia A

      HAEMOPHILIA
    82. Ton-That, TT; Doron, D; Pollard, BS; Bacher, J; Pollard, HB
      In vivo bypass of hemophilia A coagulation defect by Factor XIIa implant

      NATURE BIOTECHNOLOGY
    83. Crawley, J; Lupu, F; Westmuckett, AD; Severs, NJ; Kakkar, VV; Lupu, C
      Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    84. Ott, I; Miyagi, Y; Miyazaki, K; Heeb, MJ; Mueller, BM; Rao, LVM; Ruf, W
      Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    85. Shord, SS; Lindley, CM
      Coagulation products and their uses

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    86. Rauch, U; Nemerson, Y
      Circulating tissue factor and thrombosis

      CURRENT OPINION IN HEMATOLOGY
    87. Wiiger, MT; Prydz, H
      Cellular effects of initiation of the extrinsic pathway of blood coagulation

      TRENDS IN CARDIOVASCULAR MEDICINE
    88. Rauch, U; Nemerson, Y
      Tissue factor, the blood, and the arterial wall

      TRENDS IN CARDIOVASCULAR MEDICINE
    89. Petersen, LC; Olsen, OH; Nielsen, LS; Freskgard, PO; Persson, E
      Binding of Zn2+ to a Ca2+ loop allosterically attenuates the activity of factor VIIa and reduces its affinity for tissue factor

      PROTEIN SCIENCE
    90. Streif, W; Paes, B; Berry, L; Andrew, M; Andreasen, RB; Chan, AKC
      Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns

      BLOOD COAGULATION & FIBRINOLYSIS
    91. Johannessen, M; Andreasen, RB; Nordfang, O
      Decline of factor VIII and factor IX inhibitors during long-term treatmentwith NovoSeven (R)

      BLOOD COAGULATION & FIBRINOLYSIS
    92. Allen, GA; Monroe, DM; Roberts, HR; Hoffman, M
      The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation

      BLOOD COAGULATION & FIBRINOLYSIS
    93. Persson, E
      Structure of human coagulation activated factor VII

      BLOOD COAGULATION & FIBRINOLYSIS
    94. Negrier, C; Lienhart, A
      Overall experience with NovoSeven (R)

      BLOOD COAGULATION & FIBRINOLYSIS
    95. Ingerslev, J; Christiansen, K; Calatzis, A; Holm, M; Ebbesen, LS
      Management and monitoring of recombinant activated factor VII

      BLOOD COAGULATION & FIBRINOLYSIS
    96. McPherson, J; Sutcharitchan, P; Lloyd, J; Street, A; Jorgensen, LN; Yang, SI
      Experience with continuous infusion of recombinant activated factor VII inthe Asia-Pacific region

      BLOOD COAGULATION & FIBRINOLYSIS
    97. Lusher, JM
      Acute hemarthroses: the benefits of early versus late treatment with recombinant activated factor VII

      BLOOD COAGULATION & FIBRINOLYSIS
    98. Poon, MC; d'Oiron, R
      Recombinant activated factor VII (NovoSeven (R)) treatment of platelet-related bleeding disorders

      BLOOD COAGULATION & FIBRINOLYSIS
    99. Rapaport, SI
      Coagulation problems in liver disease

      BLOOD COAGULATION & FIBRINOLYSIS
    100. Manzano, ML; Arocena, C; Tomas, JF; Hedner, U; Quiroga, JA; Carreno, V
      Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding risk

      BLOOD COAGULATION & FIBRINOLYSIS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 17:05:08